Hemgenix (etranacogene dezaparvovec-drlb)

Adult Dosing .

Dosage forms:  INJ

Special Note

[drug name clarification]

Info: nonproprietary name = etranacogene dezaparvovec-drlb

[uses, dosing may vary]

Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing

hemophilia B

[2 x10^13 genomic copies/kg/dose IV x1]

Info: for patients on factor IX prophylaxis tx, patients with current life-threatening hemorrhage or history, or patients with repeated, serious spontaneous bleeding episodes

renal dosing

[see below]

CrCl >30: no adjustment; CrCl <30: not defined

HD/PD: not defined

hepatic dosing

[see below]

hepatic impairment: no adjustment; Info: not defined if advanced hepatic impairment, including cirrhosis, advanced liver fibrosis, or uncontrolled hepatitis B or C

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.